Sian Estdale, PhD

Dr. Sian Estdale joined Labcorp in 2002 and is head of scientific affairs for Labcorp Central Laboratory Services, Bioanalytical Services and Biopharmaceutical Chemistry, Manufacturing and Control Services. She has more than 20 years of industry experience and more than 10 years of experience as a lecturer and researcher in biomedical sciences at Bradford and Sheffield Hallam universities. She is the author of more than 60 peer-reviewed papers and industry presentations.

Luna Dong

Luna Dong joined Labcorp Central Laboratory Services’ flow cytometry team in 2022. In her current role, Luna performs complex troubleshooting and problem-solving, supporting lab operations to ensure the smooth transition of assays into production. She participates in developing/identifying new strategies, techniques and instrumentation for developing new ventures in the scientific area of expertise for Labcorp Central Labs’ global laboratory operations.

Kerry Deutsch, PhD

Dr. Kerry Deutsch leads the specialty genomics bioinformatics team at Labcorp Drug Development. The team supports data analysis and pipeline development for both the production and research and development arms of the specialty genomics lab, working on a wide variety of assays from qPCR- and array-based platforms to a full spectrum of next-generation sequencing assays including whole-genome sequencing, whole-exome sequencing and targeted panels; whole, targeted and single-cell RNA sequencing; and ctDNA sequencing.

Xiaofei Cong, PhD

Dr. Xiaofei Cong joined Labcorp Central Laboratory Services’ immunology department in May 2021. As a scientist II based in Shanghai, he has led immunoassay validation, overseen collaborative scientific projects at Asia-Pacific sites and provided cross-departmental support to meet the clinical research needs of global clients.

Di Chen, PhD

Dr. Di Chen joined Labcorp Central Laboratory Services’ anatomic pathology team in 2020, bringing comprehensive knowledge in the fields of molecular pathology, genomics, biochemistry and oncology. He serves as a scientist within the anatomic pathology and histology (APH) group at Labcorp’s central lab, where he is responsible for developing and validating APH-related assays for use in clinical trials.

Stephanie Cape, PhD

Tiyash Bose, PhD

Dr. Tiyash Bose is a staff scientist at Labcorp Drug Development and has several years of research experience in bioanalytical method development. In his current role, Tiyash supports clinical trial studies by providing scientific and technical consultations to lab technicians, project managers and sponsors and oversees the laboratory's technical aspects to help ensure quality of the laboratory test results. Before joining Labcorp, Tiyash worked in the research and development division at Meridian Bioscience Inc.

Catherine Bor-Angelier, MD

Dr. Catherine Bor-Angelier joined Labcorp Drug Development in 2020. Prior to joining Labcorp, she was head of the pathology department in a French cancer center. Catherine led a European research program on breast cancer heterogeneity using mathematic tools. She has extensive experience in anatomic pathology of the breast, in gynecology and gastroenterology oncologic pathology, as well as molecular and integrative pathology.

Marion Bonnet, PhD

Dr. Marion Bonnet is a staff scientist in the histology department. In this role, Marion is responsible for validating new immunohistochemistry and in situ hybridization assays. She is also in charge of developing the immunofluorescent multiplexing platform. She works closely with clients to deliver assays that are fit for purpose and compliant with regulatory guidelines.

Nicolas Anfossi, PhD

Dr. Nicolas Anfossi is a global director of flow cytometry at Labcorp Central Laboratory Services since mid-2018. Labcorp Central Labs performs tests on samples from early to late phases of clinical development, generating data that will help characterize their safety and efficacy. In his current role, Nicolas supports the global operations of flow cytometry department at five global sites to ensure generation of reliable data and products, while keeping compliant with stringent regulations.